ArticleJournal of the American Chemical Society2025
Photolytic Access to Oxaspirodecanes and Chromenes from Vinyldiazo Ester Cycloaddition with
Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Overview of Photochemical Reactions for the Synthesis of Aza and Oxa-Spirocyclic Compounds Under Visible Light Irradiation.Chemistry & biodiversity · 2026Review
- Direct Synthesis of Bicyclo[1.1.1]pentanes by Sequential C═C, C-C Functionalization Reactions.Journal of the American Chemical Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Synthetic methods that provide access to skeletally diverse heterocyclic motifs are poised to accelerate drug discovery and streamline the synthesis of advanced intermediates and materials. However, the development of such synthetic methods necessitates leveraging previously unexplored mechanistic pathways. We report herein an efficient blue light-emitting diode light-induced reaction of vinyldiazoacetates and quinones that produces spirocyclic dihydrofurans, featuring the synthetically challenging oxaspiro[4,5]decane core of numerous medicinal agents, agrochemicals, and natural products. In a departure from the well-established photochemical reactivity of diazo compounds, these reactions do not involve vinylcarbene intermediates formed by photolytic dinitrogen extrusion. Instead, they result from photoexcitation of the quinone to its triplet state with subsequent triplet energy transfer to the vinyldiazo ester. The subsequent addition of the vinylogous carbon of the triplet vinyldiazoacetate to the quinone oxygen affords the triplet diradical that collapses to the spirocyclic dihydrofuran upon the loss of dinitrogen. A strain release-driven and Bro̷nsted acid-catalyzed rearrangement of the spirocyclic products unravels the fused bicyclic ring system of equally synthetically and medicinally valuable chromenes, enabling facile skeletal diversification of the important heterocyclic motifs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.